Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Barr Pharmaceuticals, Inc.
U.S. Food and Drug Administration approves Duramed's Seasonique extended-cycle oral contraceptive
June 23rd, 2006
Barr Pharmaceuticals, Inc. (BRL) announced that the U.S. Food and Drug Administration (FDA) has approved its Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for SEASONIQUE (levonorgestrel/ethinyl estradiol tablets 0.15 mg/0.03 mg and ethinyl estradiol tablets 0.01 mg) extended-cycle oral contraceptive for the prevention of pregnancy. SEASONIQUE represents the next generation of extended-cycle oral contraceptives in a category the company created with the launch of the SEASONALE extended-cycle oral contraceptive in 2003. SEASONIQUE will be shipped to trade customers and will be available by prescription to women in July 2006. The company...
Source: Biotech Law Weekly (2006-06-23)
|
